Drugs & Targets EMA accepts for review Mylan’s MAA for a proposed biosimilar trastuzumab September 09, 2016Vol.42 No.33
Drugs & Targets Cumberland Pharmaceuticals begins distributing Ethyol (amifostine) for injection September 09, 2016Vol.42 No.33
Drugs & Targets 21 Hospitals Around China Will Adopt Watson for Oncology September 09, 2016Vol.42 No.33
Drugs & Targets The Department of Pathology at the Icahn School of Medicine at Mount Sinai established the Center for Computational and Systems Pathology September 06, 2016Vol.42 No.32
Drugs & Targets Novartis and MEI Pharma Receive Breakthrough Therapy Designations September 06, 2016Vol.42 No.32
Drugs & Targets Janssen Biotech Inc. submitted supplemental Biologics License Application for daratumumab (Darzalex) to FDA September 06, 2016Vol.42 No.32
Drugs & Targets Biolinerx Ltd. and MD Anderson Cancer Center signed collaboration agreement September 06, 2016Vol.42 No.32
Drugs & Targets Exact Sciences Corp. said the Centers for Medicare and Medicaid Services issued an updated Evidence of Coverage notice for Medicare Advantage plans September 06, 2016Vol.42 No.32
